Home › Kanser sa Suso › Arizona › Gilbert
Pag-aaral pangklinika para sa Kanser sa Suso sa Gilbert, AZ
9 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Gilbert (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Gilbert
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Nagre-recruitPhase 3
- Banner MD Anderson Cancer Center ( Site 0066), Gilbert
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Nagre-recruitPhase 3
- Banner MD Anderson Cancer Center-Oncology ( Site 0004), Gilbert
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Nagre-recruitPhase 3
- Ironwood Cancer & Research Centers, Gilbert
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Nagre-recruitPhase 3
- Banner Health MD Anderson AZ, Gilbert
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Nagre-recruitPhase 3
- Banner MD Anderson Cancer Center, Gilbert
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Nagre-recruitPhase 3
- Banner MD Anderson Cancer Center, Gilbert
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Nagre-recruitPhase 3
- Ironwood Cancer & Research Centers, Gilbert
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Nagre-recruitObservasyonal na pag-aaral
- Banner - MD Anderson Cancer Center, Gilbert
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY134 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA111 pag-aaral
- Nashville, TN80 pag-aaral
- Los Angeles, CA72 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Durham, NC63 pag-aaral
- Queens, NY63 pag-aaral
- Chicago, IL58 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Gilbert
- Non-Small Cell Lung Cancer12 pag-aaral
- Colorectal Cancer9 pag-aaral
- Kanser sa Baga8 pag-aaral
- Kanser (lahat ng uri)8 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg6 pag-aaral
- Metastatic Cancer6 pag-aaral
- Multiple Myeloma6 pag-aaral
- Pagkabigo ng Puso6 pag-aaral
- Sakit sa Puso at Ugat ng Dugo6 pag-aaral
- Kanser sa Pantog6 pag-aaral
- Non-Hodgkin Lymphoma5 pag-aaral
- Diffuse Large B-Cell Lymphoma5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.